Overall Status

Recruiting (4)

Completed (1)

Sign in for free

Phase

phase 1 (4)

phase 2 (1)

Sponsor

MEI Pharma, Inc. (2)

Aptevo Therapeutics (1)

Memorial Sloan Kettering Cancer Center (1)

Nurix Therapeutics, Inc. (1)

Collaborator

Adaptive Biotechnologies (1)

Intervention

me-401 (1)

nx-2127 (1)

rituximab (1)

tru-016 (anti-cd37 protein therapeutic) (1)

venetoclax monotherapy (1)

venetoclax with anti cd20 monoclonal antibody (1)

voruciclib and venetoclax (1)

voruciclib monotherapy (1)

zanubrutinib (1)

Study Documents

Intervention Type

drug (5)

Funder Type

Industry (4)

Other (1)

Study Type

Interventional (5)

Chronic Lymphocytic Leukemia (CLL)

Showing NaN - NaN of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS